15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To examine and quantify the contemporary association between androgen-deprivation therapy (ADT) and three separate endpoints: coronary artery disease (CAD), acute myocardial infarction (AMI), and sudden cardiac death (SCD), in a large USA contemporary cohort of patients with prostate cancer.

          Related collections

          Author and article information

          Journal
          BJU Int.
          BJU international
          1464-410X
          1464-4096
          Dec 2014
          : 114
          : 6b
          Affiliations
          [1 ] Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy.
          Article
          10.1111/bju.12732
          24612110
          31fecb08-f870-47c3-a3b7-87acd9f0f0ae
          © 2014 The Authors. BJU International © 2014 BJU International.
          History

          androgen-deprivation therapy,cardiovascular events,prostate cancer,side-effects

          Comments

          Comment on this article